NeoGenomics, Inc. Forecast, price target & analysts
NeoGenomics, Inc. Target price 2026 - Analyst rating & recommendation
NeoGenomics, Inc. Classifications & Recommendation
NeoGenomics, Inc. Price Target
| Target Price | $19.38 |
| Price | $18.74 |
| Potential |
3.42%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target NeoGenomics, Inc. 2027 .
The average NeoGenomics, Inc. target price is $19.38.
This is
3.42%
register free of charge
$36.75
96.10%
register free of charge
$16.16
13.77%
register free of charge
|
|
| A rating was issued by 16 analysts: 11 Analysts recommend NeoGenomics, Inc. to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the NeoGenomics, Inc. stock has an average upside potential 2027 of
3.42%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 727.33 | 812.20 |
| 10.11% | 11.67% | |
| EBITDA Margin | -7.20% | 7.09% |
| 4.11% | 198.41% | |
| Net Margin | -14.85% | 2.91% |
| 24.62% | 119.59% |
13 Analysts have issued a sales forecast NeoGenomics, Inc. 2026 . The average NeoGenomics, Inc. sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an NeoGenomics, Inc. EBITDA forecast 2026. The average NeoGenomics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 NeoGenomics, Inc. Analysts have issued a net profit forecast 2026. The average NeoGenomics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.84 | 0.18 |
| 35.48% | 121.43% | |
| P/E | 101.44 | |
| EV/Sales | 3.25 |
13 Analysts have issued a NeoGenomics, Inc. forecast for earnings per share. The average NeoGenomics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
NeoGenomics, Inc....
Current NeoGenomics, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Jul 29 2026 |
| Benchmark |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| Benchmark |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 24 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Feb 17 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Jul 29 2026 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Apr 29 2026 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Apr 29 2026 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Apr 29 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 24 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Feb 17 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
